Study Objectives: To examine the relationship between the delta lactate (3-hour lactate minus initial lactate) and in-hospital death.
Methods: This was an observational cohort study of consecutive patients diagnosed with sepsis in the emergency department who were coded as severe sepsis or septic shock during their hospital stay. Initial lactic acid, 3-hour lactic acid, and in-hospital mortality were abstracted onto pre-designed data collection sheets by abstractors blinded to outcome. A multivariate regression model was then performed to decipher predictors of in hospital mortality. The cohort included adults over the age of 18, ED diagnosis of severe sepsis, or septic shock by 2 or more of the following, temperature of more than 38 C (100.4 F) or less than 36 C (96.8 F), pulse rate of more than 90 beats per minute, respiratory rate of more than 20 breaths per minute, or abnormal white blood cell count (>12,000/mL or < 4,000/mL or >10% immature [band] forms) and associated with organ dysfunction, hypoperfusion, or hypotension (systolic blood pressure of less than 90 mmHg or a rapid decrease from baseline) or persistent hypotension and perfusion abnormalities despite adequate fluid resuscitation. Patients who developed sepsis after the ED visit (during hospitalization), patients transferred from another facility, or were less than 18 years of age were excluded.
Results: The cohort consisted of 163 patients who had an initial lactate drawn, 130 of which also got a 3-hour lactate. The median initial lactate was 2.64 with an interquartile range (IQR) of 1.71 to 4.62, and a range of 0.49 to 18.04. The median repeat lactate was 2.58, with an IQR of 1.4 to 3.9, and a range of 0.4 to 28.7. 25% of the cohort died during their hospital stay. For men, the in-hospital death rate was 23%, and for women, 29%. The delta lactate was significantly higher in women (p¼0.0070), driven by a lower initial lactate (P¼0.0277). Multivariate regression model controlled for age and sex demonstrated a statistically significant correlation between an increase in the delta lactate and in hospital death (p¼0.0323, R2¼11.3%).
Conclusions: An increase in the 3-hour lactic acid as compared to the initial lactic acid was significantly associated with higher in hospital death in our cohort. This information may be utilized to accelerate a higher level of care for these patients.
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Evaluating the Clinical Respiratory Score for Initiating High Flow Nasal Cannula in the Pediatric Emergency Department Cheng A, Simon H, Travers C, Hebbar KB/Emory University, Atlanta, GA Study Objectives: There are no established guidelines for the initiation of oxygen therapy in pediatric patients. With the increased utilization of high flow nasal cannula (HFNC) for patients with respiratory failure, it is critical to develop a systematic approach for the initiation of this oxygen delivery modality. Currently at our institution, providers utilize the Clinical Respiratory Score (CRS) to assess all respiratory distress patients in the emergency department (ED). CRS is a 12-point assessment that includes respiratory rate, work of breathing, wheezing, hypoxia, dyspnea, and cough. While this score serves as a guidance for asthma treatment, it is not extended to HFNC therapy decisionmaking. We investigate the correlation between CRS and HFNC use in the ED.
Methods: To determine the relationship between ED-assessed CRS and respiratory therapy, we completed a structured explicit retrospective chart review at a single institution between 2/1/15-12/13/16. We included all patients, 0-18 years old, admitted to the floor or Pediatric Intensive Care Unit (PICU) from the ED with an ED-assessed CRS. If a patient has multiple CRS during their course in the ED, only the first CRS was used in the analysis. Diagnosis code were used to include patients with asthma, pneumonia, bronchiolitis, viral upper respiratory illness, wheezing, and hypoxia. Patients who have tracheostomy tube, baseline oxygen dependence, cystic fibrosis, and croup were excluded from the study. We calculated the predicative values, sensitivity, and specificity for the CRS relative to the incidence of HFNC initiation in the ED. Additional stratification by diagnosis was conducted to understand patterns of assessment between patients with bronchiolitis, pneumonia, and asthma.
Results: A total of 1,093 patients were included in the assessment. The median age was 3.1 years (median 0.9, IQR 7.2). 63% of the cohort had a diagnosis of asthma; 35% of the cohort had a diagnosis of bronchiolitis; and 29.6% of the cohort had a diagnosis of pneumonia. With respect to ED-based supplemental oxygen treatment, 23% of the cohort received HFNC compared to 51% for NC. Patients receiving HFNC received a statistically significantly higher CRS compared to non-HFNC (HFNC mean 4.57, SD 1.87 versus non-HFNC mean 3.28, SD 1.98; p<0.001). Differences in distributions are slightly more pronounced for the bronchiolitis cohort (HFNC mean 4.26, SD ¼ 1.77 versus non-HFNC mean 2.65, SD 1.76; p<0.001) compared to asthma (HFNC mean 5.05, SD ¼ 1.73 versus non-HFNC mean 3.71, SD 1.92; p<0.001) and pneumonia (HFNC mean 4.63, SD ¼ 2.17 versus non-HFNC mean 3.05, SD 2.07; p<0.001). Stratification by diagnosis showed a CRS of 5 in the asthma cohort has sensitivity of 65% and specificity of 67%, and CRS of 4 in the bronchiolitis cohort has sensitivity of 71% and specificity of 71%.
Conclusions: Based on this cohort review, CRS was not a highly sensitive or specific tool to discern the need for HFNC. Initiation of HFNC within the ED has shown to be an effective rescue modality for some patients in respiratory distress, but also requires costlier equipment and higher likelihood of PICU observation. It is therefore critical to develop a clinical support tool to help guide providers in the usage of HFNC in the ED. Additional refinement and validation of components within CRS (or other respiratory scoring tools) should be explored in order to establish guidelines and best practices for initiating HFNC therapy.
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Blood Eosinophils, Immunoglobulin E, and Bronchiolitis Severity Mitri EJ, Zheng DX, Garg V, Crifase CC, Herrera NM, Espinola JA, Tierney C, Hasegawa K, Camargo CA, Jr./Massachusetts General Hospital, Boston, MA Study Objectives: Bronchiolitis is the leading cause of hospitalization for US infants. Despite ongoing research, there are currently no effective targeted therapies for treatment of bronchiolitis. Previous studies have shown higher blood eosinophil levels and higher immunoglobulin E (IgE) levels are associated with higher bronchiolitis severity. The aim of this study was to investigate the association between blood eosinophil and IgE levels at time of hospitalization and acute severity among infants hospitalized for bronchiolitis.
Methods: We performed a 17-center, prospective cohort study from 2011 to 2014. Children <1-year old hospitalized with a physician diagnosis of bronchiolitis were enrolled. Of the 1016 children in the cohort, 880 (87%) had eosinophil quantification. Serum specific IgE levels at index hospitalization for all participants also were obtained. We defined higher severity in 2 ways: 1) requirement of intensive care therapy (ie, intensive care unit [ICU] admission, mechanical ventilation, and/or continuous positive pressure ventilation [CPAP]), and 2) longer hospital length of stay (LOS). Multivariable logistic regression was used to analyze the association between biomarkers and bronchiolitis severity, with the final model adjusted for demographics, clinical characteristics, and potential clustering by site.
Results: Among 880 infants in the analytical cohort, the median age was 3.0 months (interquartile range [IQR] 1.6-5.7 months), 60% were male, and 44% were non-Hispanic white. At hospitalization, 18% had blood eosinophil levels of 3%, and 20% had specific IgE of 0.35kU/L. With regard to outcomes, 15% received intensive care therapy, and 39% had increased hospital LOS. In multivariable models examining each biomarker in separate models, blood eosinophil level of 3% was not significantly associated with intensive care therapy (OR 0.89, 95% CI 0.50 -1.56), nor hospital LOS (OR 0.78, 95% CI 0.58 -1.06). By contrast, specific IgE had potential association with intensive care therapy (OR 1.35, 95% CI 0.87 -2.11) but not hospital LOS. In a multivariable model for intensive care therapy, adjusted for both blood eosinophils and specific IgE, eosinophils remained non-significant while higher specific IgE was associated with higher risk (OR 1.53, 95% CI 0.99 -2.37; p¼0.05).
Conclusions: In this multicenter study of infants hospitalized with bronchiolitis, we found that blood eosinophil level of 3% was not associated with the use of intensive care therapy and/or increased hospital LOS. By contrast, specific IgE had a borderline significant association with intensive care therapy, but not hospital LOS. Although neither biomarker is likely to provide helpful prognostic information, the specific IgE finding provides potential insight into the pathophysiology of more severe bronchiolitis. Further research is warranted into this mechanism, and other potential biomarkers for higher bronchiolitis severity. Study Objectives: Mental health disorders are among the most common diseases of childhood, with an estimated 17.1 million children in the US affected by a psychiatric disorder. Between 2-5% of all ED visits among children are related to mental healthrelated concerns, and rates are increasing nationally. It is also known that minority children have less access to needed mental health services than non-minority children. This study aims to test the hypotheses that 1) minority children have higher rates of mental health-related ED visits than non-minority children, and 2) rates of ED visits for mental health-related complaints in minority children are increasing more than rates in non-minority children.
Methods: We performed a retrospective cross-sectional study using Pediatric Health Information System (PHIS) data from 2012 through 2016. We included children 21 years old with an ICD-9/10 diagnosis for a mental health illness. Using US census data, we determined annual mental health-related visit rates overall and by race/ethnicity (non-Hispanic [NH] white, NH black, Hispanic, and NH Other). We performed logistic regression to report racial/ethnic differences in mental health-related ED visits and performed linear regression to measure racial/ethnic differences in visit trends over time.
Results: There were 293,198 patients with mental health-related diagnoses in pediatric EDs (58,640/year). The mean age was 13.3 (SD 3.9) years and the majority were publicly insured (54.7%). Compared to NH white children (51.5 per 100,000 population), NH black (78.4; OR 1.5, 95% CI 1.5, 1.5) and NH Other (79.2; OR 1.5, 95% CI 1.5, 1.6) children had higher rates of mental health-related diagnoses. Rates of mental health-related visits increased over time with 50.4 visits per 100,000 children in 2012 compared to 78.5 in 2016 (p¼0.003) . When stratified by race/ethnicity, mental health-related PED visits increased at a higher rate among NH black (b¼11.9) when compared to NH white (b¼6.6) children (p < 0.05) (Figure) .
Conclusions: Rates of mental health-related visits to PEDs continue to increase. Furthermore, children of NH black race/ethnicity have higher rates of mental healthrelated ED visits and these rates are increasing at a higher rate than NH white children. Absent other resources in the community, these results indicate a need for increased capacity of PEDs to manage mental health-related complaints, especially among minority populations. Study Objectives: Asthma is one of the leading causes of childhood emergency department (ED) visits and hospitalizations in the U.S. In Camden, New Jersey, pediatric asthma-related hospitalizations nearly doubled between 2002-2012. Our goal was to identify patient-centered interventions that hold the most promise for reducing asthma-related pediatric acute care utilization.
Methods: The study was conducted in 3 phases using sequential mixed methods. Phase 1 was a cluster analysis of claims data from 3 Camden City hospitals that identified groups of patients with similar patterns of acute care utilization. Phase 2 involved 4 focus groups of 5-9 children or their caregivers. Participants were chosen through Camden's Health Information Exchange (HIE) and represented either the low-or high-utilizer clusters found in Phase 1. Focus groups discussed the community's perspective regarding challenges to controlling asthma and ways to reduce asthma-related ED use and hospitalizations. In Phase 3, an expert panel of key stakeholders was presented with the results of Phases 1 and 2, and rated a set of interventions to implement in Camden.
